CancerNet: a database for decoding multilevel molecular interactions across diverse cancer types

Protein–protein interactions (PPIs) and microRNA (miRNA)–target interactions are important for deciphering the mechanisms of tumorigenesis. However, current PPI databases do not support cancer-specific analysis. Also, no available databases can be used to retrieve cancer-associated miRNA–target interactions. As the pathogenesis of human cancers is affected by several miRNAs rather than a single miRNA, it is needed to uncover miRNA synergism in a systems level. Here for each cancer type, we constructed a miRNA–miRNA functionally synergistic network based on the functions of miRNA targets and their topological features in that cancer PPI network. And for the first time, we report the cancer-specific database CancerNet (http://bis.zju.edu.cn/CancerNet), which contains information about PPIs, miRNA–target interactions and functionally synergistic miRNA–miRNA pairs across 33 human cancer types. In addition, PPI information across 33 main normal tissues and cell types are included. Flexible query methods are allowed to retrieve cancer molecular interactions. Network viewer can be used to visualize interactions that users are interested in. Enrichment analysis tool was designed to detect significantly overrepresented Gene Ontology categories of miRNA targets. Thus, CancerNet serves as a comprehensive platform for assessing the roles of proteins and miRNAs, as well as their interactions across human cancers.

[1]  H. Kung,et al.  miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT , 2014, Oncogene.

[2]  Adam J. Smith,et al.  The Database of Interacting Proteins: 2004 update , 2004, Nucleic Acids Res..

[3]  C. Sander,et al.  Analysis of microRNA-target interactions across diverse cancer types , 2013, Nature Structural &Molecular Biology.

[4]  Yun Xiao,et al.  MiRNA–miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features , 2010, Nucleic acids research.

[5]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[6]  Lucia Altucci,et al.  Identification of microRNA Expression Patterns in Cutaneous and Uveal Melanoma Cell Lines , 2014, Tumori.

[7]  N. Seki,et al.  Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer , 2011, British Journal of Cancer.

[8]  Tasneem Motiwala,et al.  Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer , 2008, Journal of Biological Chemistry.

[9]  Rafael C. Jimenez,et al.  The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..

[10]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[11]  Jingqiang Wang,et al.  Identification of miR-133b and RB1CC1 as Independent Predictors for Biochemical Recurrence and Potential Therapeutic Targets for Prostate Cancer , 2014, Clinical Cancer Research.

[12]  Yanshu Li,et al.  miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer. , 2014, Cellular signalling.

[13]  M E J Newman,et al.  Community structure in social and biological networks , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2012 update , 2011, Nucleic Acids Res..

[15]  Cheng Liang,et al.  Mirsynergy: detecting synergistic miRNA regulatory modules by overlapping neighbourhood expansion , 2014, Bioinform..

[16]  Nectarios Koziris,et al.  DIANA-microT web server: elucidating microRNA functions through target prediction , 2009, Nucleic Acids Res..

[17]  Y. Okamoto,et al.  Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. , 2011, International journal of oncology.

[18]  N. Seki,et al.  The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer , 2011, British Journal of Cancer.

[19]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[20]  Kara Dolinski,et al.  The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..

[21]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Nicholas T. Ingolia,et al.  Mammalian microRNAs predominantly act to decrease target mRNA levels , 2010, Nature.

[23]  Ilan Y. Smoly,et al.  The TissueNet database of human tissue protein–protein interactions , 2012, Nucleic Acids Res..

[24]  Christopher B. Burge,et al.  Alternative Splicing of RNA Triplets Is Often Regulated and Accelerates Proteome Evolution , 2012, PLoS biology.

[25]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[26]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[27]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[28]  F. Bruggeman,et al.  Cancer: a Systems Biology disease. , 2006, Bio Systems.

[29]  T. Mikkelsen,et al.  The NIH Roadmap Epigenomics Mapping Consortium , 2010, Nature Biotechnology.

[30]  Jan Krüger,et al.  RNAhybrid: microRNA target prediction easy, fast and flexible , 2006, Nucleic Acids Res..

[31]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[32]  Tamás Korcsmáros,et al.  ComPPI: a cellular compartment-specific database for protein–protein interaction network analysis , 2014, Nucleic Acids Res..

[33]  N. Rajewsky,et al.  Cell-type-specific signatures of microRNAs on target mRNA expression. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Quan Liu,et al.  Strategies to identify microRNA targets: new advances. , 2010, New biotechnology.

[35]  Hsien-Da Huang,et al.  miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions , 2013, Nucleic Acids Res..

[36]  Mauno Vihinen,et al.  Identification of candidate disease genes by integrating Gene Ontologies and protein-interaction networks: case study of primary immunodeficiencies , 2008, Nucleic acids research.

[37]  N. Seki,et al.  The functional significance of miR-1 and miR-133a in renal cell carcinoma. , 2012, European journal of cancer.

[38]  L. Tian,et al.  Four MicroRNAs Promote Prostate Cell Proliferation with Regulation of PTEN and Its Downstream Signals In Vitro , 2013, PloS one.

[39]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[40]  Michael Kertesz,et al.  The role of site accessibility in microRNA target recognition , 2007, Nature Genetics.

[41]  Gary D. Bader,et al.  Cytoscape Web: an interactive web-based network browser , 2010, Bioinform..

[42]  Anton J. Enright,et al.  MicroRNA targets in Drosophila , 2003, Genome Biology.

[43]  Giorgio Valle,et al.  The Gene Ontology in 2010: extensions and refinements , 2009, Nucleic Acids Res..

[44]  B. Frey,et al.  Using expression profiling data to identify human microRNA targets , 2007, Nature Methods.

[45]  Sung-Chou Li,et al.  Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer. , 2012, Oncology reports.

[46]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[47]  Q. Kan,et al.  MicroRNA-1 (miR-1) inhibits gastric cancer cell proliferation and migration by targeting MET , 2015, Tumor Biology.

[48]  Hsien-Da Huang,et al.  Investigating microRNA-Target Interaction-Supported Tissues in Human Cancer Tissues Based on miRNA and Target Gene Expression Profiling , 2014, PloS one.

[49]  A. Ballabio,et al.  MicroRNA target prediction by expression analysis of host genes. , 2009, Genome research.

[50]  A. Pasquinelli,et al.  Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation , 2005, Cell.

[51]  C. Young,et al.  miR‐141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein , 2012, The Prostate.

[52]  H. Kitano.  Systems Biology: A Brief Overview , 2002, Science.

[53]  Y. Akao,et al.  Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways. , 2013, Cancer letters.

[54]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[55]  Philip Resnik,et al.  Using Information Content to Evaluate Semantic Similarity in a Taxonomy , 1995, IJCAI.

[56]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[57]  Diego Megias,et al.  Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways. , 2013, Endocrine-related cancer.

[58]  A. Bjartell,et al.  Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1 , 2013, PloS one.

[59]  A. Barabasi,et al.  Interactome Networks and Human Disease , 2011, Cell.

[60]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[61]  Xiaowei Wang,et al.  miRDB: an online resource for microRNA target prediction and functional annotations , 2014, Nucleic Acids Res..

[62]  Yonghong Xiao,et al.  microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma. , 2012, Cancer discovery.

[63]  Ioannis Xenarios,et al.  DIP: The Database of Interacting Proteins: 2001 update , 2001, Nucleic Acids Res..

[64]  R. Sharan,et al.  Protein networks in disease. , 2008, Genome research.

[65]  H. Lodish,et al.  Distinct roles for miR‐1 and miR‐133a in the proliferation and differentiation of rhabdomyosarcoma cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[66]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[67]  R. Stephens,et al.  Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. , 2008, Cancer research.

[68]  Sheila M. Reynolds,et al.  Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. , 2013, Cancer cell.

[69]  A. Russo,et al.  MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? , 2012, Oncogenesis.